Leslie C.G. Campbell Purchases 15,000 Shares of PetMed Express, Inc. (NASDAQ:PETS) Stock

PetMed Express, Inc. (NASDAQ:PETS - Get Free Report) Director Leslie C.G. Campbell purchased 15,000 shares of the firm's stock in a transaction dated Wednesday, December 4th. The stock was purchased at an average cost of $5.38 per share, with a total value of $80,700.00. Following the acquisition, the director now directly owns 70,000 shares in the company, valued at $376,600. This trade represents a 27.27 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

PetMed Express Trading Up 8.3 %

Shares of PETS stock traded up $0.44 during trading hours on Friday, hitting $5.75. 549,165 shares of the company were exchanged, compared to its average volume of 338,296. PetMed Express, Inc. has a 52 week low of $2.90 and a 52 week high of $7.90. The business has a 50 day moving average of $4.43 and a two-hundred day moving average of $3.98. The company has a market capitalization of $118.80 million, a PE ratio of -95.83 and a beta of 0.71.

PetMed Express (NASDAQ:PETS - Get Free Report) last released its earnings results on Wednesday, November 6th. The company reported $0.11 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.06) by $0.17. The firm had revenue of $59.57 million during the quarter, compared to analysts' expectations of $66.02 million. PetMed Express had a negative return on equity of 1.00% and a negative net margin of 0.37%. On average, research analysts forecast that PetMed Express, Inc. will post 0.24 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised PetMed Express from a "hold" rating to a "buy" rating in a research note on Tuesday, November 12th.

Institutional Investors Weigh In On PetMed Express

Several institutional investors have recently bought and sold shares of PETS. Vanguard Group Inc. raised its holdings in shares of PetMed Express by 0.8% in the first quarter. Vanguard Group Inc. now owns 1,186,485 shares of the company's stock valued at $5,683,000 after purchasing an additional 9,226 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in PetMed Express by 48.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 129,229 shares of the company's stock valued at $620,000 after purchasing an additional 42,125 shares in the last quarter. SG Americas Securities LLC acquired a new stake in PetMed Express in the 2nd quarter valued at $46,000. Legacy Advisors LLC bought a new stake in PetMed Express during the 2nd quarter worth about $96,000. Finally, Federated Hermes Inc. boosted its stake in shares of PetMed Express by 54.5% during the 2nd quarter. Federated Hermes Inc. now owns 606,430 shares of the company's stock worth $2,456,000 after buying an additional 213,903 shares during the last quarter. Institutional investors own 73.33% of the company's stock.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.